CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-20 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −3,000 | $38.83 | $116K | 88,762 |
| 2018-03-19 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −3,000 | $41.99 | $126K | 91,762 |
| 2018-02-16 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −4,000 | $46.93 | $188K | 97,262 |
| 2018-02-16 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −2,500 | $48.08 | $120K | 94,762 |
| 2018-02-15 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −6,500 | $46.77 | $304K | 99,056 |
| 2018-02-15 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise | +5,132 | 104,188 | ||
| 2018-02-15 | MCGRATH JOHN EVP & Chief Financial Officer | Shares withheld for taxes | −2,926 | $47.05 | $138K | 101,262 |
| 2018-02-15 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise · Restricted Stock Units | −5,132 | 0 | ||
| 2018-02-09 | MCGRATH JOHN EVP & Chief Financial Officer | Shares withheld for taxes | −4,819 | $41.70 | $201K | 105,556 |
| 2018-02-06 | MCGRATH JOHN EVP & Chief Financial Officer | Grant or award | +25,000 | 114,654 | ||
| 2018-02-06 | MCGRATH JOHN EVP & Chief Financial Officer | Shares withheld for taxes | −4,279 | $35.80 | $153K | 110,375 |
| 2018-02-06 | MCGRATH JOHN EVP & Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-01-12 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise | +30,000 | $11.00 | $330K | 123,154 |
| 2018-01-12 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −3,500 | $22.32 | $78K | 119,654 |
| 2018-01-12 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −30,000 | $25.00 | $750K | 89,654 |
| 2018-01-12 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise · Employee Stock Option (Right to Buy) | −30,000 | 10,000 | ||
| 2018-01-11 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −3,500 | $20.77 | $73K | 93,154 |
| 2017-12-29 | MCGRATH JOHN EVP & Chief Financial Officer | Sale | −32,000 | $20.00 | $640K | 96,654 |
| 2017-11-15 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise | +7,697 | 128,654 | ||
| 2017-11-15 | MCGRATH JOHN EVP & Chief Financial Officer | Option exercise · Restricted Stock Units | −7,697 | 5,132 |
Page 1 of 2 · 30 trades